| 1996 |
944: dimerization, AHR/ARNT |
1697: Increase, DNMT expression |
Oct 30, 2019 |
Oct 30, 2019 |
1 AOP
|
| 2682 |
944: dimerization, AHR/ARNT |
2020: Decrease, sox9 expression |
Jun 30, 2022 |
Jun 30, 2022 |
None
|
| 2683 |
944: dimerization, AHR/ARNT |
2021: Increase, slincR expression |
Jun 30, 2022 |
Sep 8, 2022 |
2 AOPs
|
| 2359 |
1869: Diminished Protective Response to ROS |
1845: Coagulation |
Apr 20, 2021 |
Jan 26, 2024 |
1 AOP
|
| 2413 |
1869: Diminished Protective Response to ROS |
1895: inflammasome activity, increased |
Jun 25, 2021 |
Jun 25, 2021 |
1 AOP
|
| 2537 |
1958: Direct hERG channel blockage |
1960: Inhibition of Ikr |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 3145 |
1260: Direct mitochondrial inhibition |
177: Mitochondrial dysfunction |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 737 |
721: Disorganization, Meiotic Spindle |
752: Altered, Meiotic chromosome dynamics |
Nov 29, 2016 |
Dec 13, 2019 |
1 AOP
|
| 2249 |
1830: Displacement, Serum thyroxine (T4) from carrier protein |
959: Increased, Free serum thyroxine (T4) |
Dec 9, 2020 |
Dec 9, 2020 |
2 AOPs
|
| 2246 |
958: Displacement, Serum thyroxine (T4) from transthyretin |
959: Increased, Free serum thyroxine (T4) |
Dec 9, 2020 |
Dec 9, 2020 |
1 AOP
|
| 3249 |
2238: Disrupted calcium-dependent signalling pathway |
2239: Increased, disregulation of smooth muscle cells |
Jun 19, 2024 |
Jun 19, 2024 |
None
|
| 3252 |
2238: Disrupted calcium-dependent signalling pathway |
2237: Increased, Endothelin protein |
Jun 19, 2024 |
Jun 19, 2024 |
None
|
| 3210 |
2225: Disrupted Lipid Storage |
327: Accumulation, Fatty acid |
May 8, 2024 |
May 8, 2024 |
1 AOP
|
| 3211 |
2225: Disrupted Lipid Storage |
291: Accumulation, Triglyceride |
May 8, 2024 |
May 8, 2024 |
1 AOP
|
| 2481 |
1882: Oocyte meiosis, disrupted |
1883: Ovarian follicle pool, reduced |
Sep 13, 2021 |
Nov 11, 2021 |
1 AOP
|
| 3221 |
2227: Disrupted PPAR isoform nuclear signaling |
2224: Dysregulation of transcriptional expression within PPAR signaling network |
May 14, 2024 |
May 23, 2024 |
1 AOP
|
| 3222 |
2227: Disrupted PPAR isoform nuclear signaling |
179: Decreased, Mitochondrial fatty acid beta-oxidation |
May 14, 2024 |
May 14, 2024 |
None
|
| 2615 |
1977: Altered kinetics of sodium channel |
698: Altered, Action Potential |
Mar 25, 2022 |
Mar 25, 2022 |
None
|
| 2625 |
1977: Altered kinetics of sodium channel |
1983: Disruption in action potential generation |
Mar 31, 2022 |
Mar 31, 2022 |
1 AOP
|
| 1761 |
1536: Disruption, Intracellular calcium mobilization |
1537: Disruption, Sarcomere assembly |
Jun 21, 2018 |
Jun 21, 2018 |
1 AOP
|
| 911 |
898: Disruption, Lysosome |
257: Increase, ROS production |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 921 |
898: Disruption, Lysosome |
209: Peptide Oxidation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 993 |
898: Disruption, Lysosome |
177: Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 12, 2018 |
2 AOPs
|
| 1679 |
898: Disruption, Lysosome |
709: Increase, Cytotoxicity (renal tubular cell) |
Oct 25, 2017 |
Oct 25, 2017 |
1 AOP
|
| 715 |
720: Disruption, Microtubule dynamics |
721: Disorganization, Meiotic Spindle |
Nov 29, 2016 |
Dec 13, 2019 |
1 AOP
|